Upon a thorough investigation of EZH2 as a prospective therapeutic target for human cancer, its significance in cancer progression has been meticulously investigated and enhanced, earning its recognition as a prime focus in tumor therapy. This evidence concerns the gene EZH2 and neoplasm.